The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-{[(1R,2S)-2-Aminocyclohexyl]amino}-5-chloro-2-(3-methylanilino)pyridine-3-carboxamide ID: ALA4548027
PubChem CID: 56599956
Max Phase: Preclinical
Molecular Formula: C19H24ClN5O
Molecular Weight: 373.89
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(Cl)cc2C(N)=O)c1
Standard InChI: InChI=1S/C19H24ClN5O/c1-11-5-4-6-12(9-11)23-18-13(17(22)26)10-14(20)19(25-18)24-16-8-3-2-7-15(16)21/h4-6,9-10,15-16H,2-3,7-8,21H2,1H3,(H2,22,26)(H2,23,24,25)/t15-,16+/m0/s1
Standard InChI Key: YFGWKJNKZYWKQK-JKSUJKDBSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.4230 -10.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4218 -11.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1299 -11.9345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8395 -11.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8367 -10.7024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1281 -10.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7152 -10.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7150 -9.4804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0076 -10.7063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7138 -11.9336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7131 -12.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0050 -13.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0040 -13.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7119 -14.3836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4223 -13.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4198 -13.1561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5479 -11.9325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5492 -12.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8391 -13.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8385 -13.9682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5450 -14.3795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2539 -13.9711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2562 -13.1513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9630 -12.7412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2958 -14.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5429 -10.2911 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
7 9 2 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
4 17 1 0
18 17 1 1
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 1
13 25 1 0
5 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.89Molecular Weight (Monoisotopic): 373.1669AlogP: 3.57#Rotatable Bonds: 5Polar Surface Area: 106.06Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.96CX Basic pKa: 9.92CX LogP: 4.74CX LogD: 2.34Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.64Np Likeness Score: -1.08
References 1. Taniguchi T, Inagaki H, Baba D, Yasumatsu I, Toyota A, Kaneta Y, Kiga M, Iimura S, Odagiri T, Shibata Y, Ueda K, Seo M, Shimizu H, Imaoka T, Nakayama K.. (2019) Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity., 10 (5): [PMID:31097992 ] [10.1021/acsmedchemlett.8b00631 ]